Intervention to Reduce Bisphenol A Exposure in Women

Environmental Exposure Clinical Trial

Official title:

Intervention to Reduce Bisphenol A Exposure in Women

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03440307
• Other study ID #: Cal Poly 11/12/2015
• Status: Completed
• Phase: N/A
• First received: February 8, 2018
• Last updated: February 20, 2018
• Start date: November 12, 2015
• Est. completion date: November 11, 2017

Study information

• Verified date: February 2018
• Source: California Polytechnic State University-San Luis Obispo
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether a 3-week intervention reduces urinary Bisphenol A (BPA) in women with obesity

Description:

The purpose of this study is reduce BPA exposure in women. The intervention is rooted in social cognitive theory, and is applied to environmental health.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: November 11, 2017
• Est. primary completion date: November 11, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• BMI >29.9

• Age 18-50 years

• Non-smoking

• English speaking

Exclusion Criteria:

• History of infertility

• Type 2 or Type 1 diabetes

• Cardiovascular disease, or any other metabolic disease/complication

• History of major psychiatric illness, drug abuse, or unsafe dieting practices

• History of bariatric surgery

• Pregnant women or women expecting or trying to become pregnant

• Participating in other studies

Related Conditions & MeSH terms

• Environmental Exposure

Intervention

Behavioral:
• Face-to-Face Meetings
Participants received health and fitness education, and a face-to-face 3-week intervention to reduce bisphenol exposure.
• Email Only
Participants received health and fitness education.

Locations

Country	Name	City	State
United States	California Polytechnic State University	San Luis Obispo	California

Sponsors (1)

Lead Sponsor	Collaborator
California Polytechnic State University-San Luis Obispo

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from Baseline Urine BPA at 3-weeks	Change in urinary BPA measured at baseline and 3-weeks	Single urine overnight fasted sample at baseline (date of randomization) and 3-weeks
Secondary	Change from Baseline Urine BPS and BPF at 3-weeks	Change in urinary BPS and BPF measured at baseline and 3-weeks	Single urine overnight fasted sample at baseline (date of randomization) and 3-weeks
Secondary	Change from Baseline Weight at 3-weeks	Change in body weight measured at baseline and 3-weeks	Overnight fasted weight at baseline (date of randomization) and 3-weeks